Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Nitrotyrosine formation is a hallmark of vascular inflammation, with polymorphonuclear neutrophil-derived (PMN-derived) and monocyte-derived myeloperoxidase (MPO) being shown to catalyze this posttranslational protein modification via oxidation of nitrite (NO(2)(-)) to nitrogen dioxide (NO(2)(*)). Herein, we show that MPO concentrates in the subendothelial matrix of vascular tissues by a transcytotic mechanism and serves as a catalyst of ECM protein tyrosine nitration. Purified MPO and MPO released by intraluminal degranulation of activated human PMNs avidly bound to aortic endothelial cell glycosaminoglycans in both cell monolayer and isolated vessel models. Cell-bound MPO rapidly transcytosed intact endothelium and colocalized abluminally with the ECM protein fibronectin. In the presence of the substrates hydrogen peroxide (H(2)O(2)) and NO(2)(-), cell and vessel wall-associated MPO catalyzed nitration of ECM protein tyrosine residues, with fibronectin identified as a major target protein. Both heparin and the low-molecular weight heparin enoxaparin significantly inhibited MPO binding and protein nitrotyrosine (NO(2)Tyr) formation in both cultured endothelial cells and rat aortic tissues. MPO(-/-) mice treated with intraperitoneal zymosan had lower hepatic NO(2)Tyr/tyrosine ratios than did zymosan-treated wild-type mice. These data indicate that MPO significantly contributes to NO(2)Tyr formation in vivo. Moreover, transcytosis of MPO, occurring independently of leukocyte emigration, confers specificity to nitration of vascular matrix proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029 · cited 11×
“MPO has also been proposed to catalyze ONOO––dependent tyrosine nitration (67).”
BackgroundInfluentialSelf-citationNitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., & van der Vliet, A. (1998) · Nature · doi:10.1038/34923 · Cited by 1,496 · cited 1×
“Blood was drawn from healthy human volunteers after written informed consent, and isolation of PMNs was performed as described previously (12).”
MethodSelf-citationCell transformation by the superoxide-generating oxidase Mox1
Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480 · cited 1×
“There are also a diversity of other sources of substrates to support these MPO-catalyzed reactions during inflammation, including the NADPH oxidase of PMNs, cytokine-activated sources of intracellular production of O2•– and H2O2, and the enhanced vascular smooth muscle cell, fibroblast, and endothelial expression of g…”
BackgroundDaugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269 · cited 2×
“Thus, the intraluminal release of this highly cationic protein may facilitate electrostatic interactions with the negatively charged endothelial plasma membrane, thereby favoring neutrophilindependent binding of MPO with the vascular intima (18, 19).”
BackgroundExtensive Nitration of Protein Tyrosines in Human Atherosclerosis Detected by Immunohistochemistry
Beckmann, J. S., Ye, Y. Z., Anderson, P. G., Chen, J., Accavitti, M. A., Tarpey, M. M., & White, C. R. (1994) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1994.375.2.81 · Cited by 1,123
Self-citationQuantitative Aspects of the Production of Superoxide Anion Radical by Milk Xanthine Oxidase
Fridovich, I. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62884-4 · Cited by 1,035
Ischiropoulos, H. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0755 · Cited by 1,022
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Zhang, R. (2001) · JAMA · doi:10.1001/jama.286.17.2136 · Cited by 918
Research works printed but not linked: 6
- Brown, 1997, Semin Hematol, 34, 319
- Deneke, 1989, Am J Physiol, 257, L163
- 10.1159/000028274 · doi:10.1159/000028274
- 10.1136/gut.47.1.88 · doi:10.1136/gut.47.1.88
- Darien, 1998, Shock, 9, 274, 10.1097/00024382-199804000-00007 · doi:10.1097/00024382-199804000-00007
- Vercellotti, 1983, Blood, 62, 1063, 10.1182/blood.V62.5.1063.1063 · DOI
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Myeloperoxidase: friend and foe
Klebanoff, S. J. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1204697 · Cited by 2,282
“1 M [310], would suggest that the oxidation of nitrite is not a major source of oxidants in the phagosome, although the oxidation of nitrite in the extracellular fluid by MPO and H2O2 released from phagocytes may occur in vivo [311].”
BackgroundMyeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes
Baldus, S., Heeschen, C., Meinertz, T., Zeiher, A. M., Eiserich, J. P., Münzel, T., Simoons, M. L., & Hamm, C. W. (2003) · Circulation · doi:10.1161/01.cir.0000090690.67322.51 · Cited by 1,013
Self-citationDysfunctional HDL and atherosclerotic cardiovascular disease
Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.124 · Cited by 822
Myeloperoxidase and Cardiovascular Disease
Nicholls, S. J., & Hazen, S. L. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000163262.83456.6d · Cited by 795
Chemical biology of peroxynitrite: Kinetics, diffusion, and radicals
Ferrer-Sueta, G., & Radi, R. (2009) · ACS Chemical Biology · doi:10.1021/cb800279q · Cited by 776
Zheng, L., Nukuna, B., Brennan, M.-L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421109 · Cited by 737
Self-citationMyeloperoxidase, a Leukocyte-Derived Vascular NO Oxidase
Eiserich, J. P., Baldus, S., Brennan, M.-L., Ma, W., Zhang, C., Tousson, A., Castro, L., Lusis, A. J., Nauseef, W. M., White, C. R., et al. (2002) · Science · doi:10.1126/science.1106830 · Cited by 685
Self-citationGraham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Mammalian Heme Peroxidases: From Molecular Mechanisms to Health Implications
Davies, M. J., Hawkins, C. L., Pattison, D. I., & Rees, M. D. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1927 · Cited by 560
Myeloperoxidase: Molecular Mechanisms of Action and Their Relevance to Human Health and Disease
van der Veen, B. S., de Winther, M. P. J., & Heeringa, P. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2538 · Cited by 518
Biological selectivity and functional aspects of protein tyrosine nitration
Ischiropoulos, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00814-3 · Cited by 500
Brennan, M.-L., Wu, W., Fu, X., Shen, Z., Song, W., Frost, H., Vadseth, C., Narine, L., Lenkiewicz, E., Borchers, M. T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112400200 · Cited by 486
Self-citationThe wanderings of a free radical
Halliwell, B. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.11.008 · Cited by 467
“Peroxynitrite formation is usually implicated by the presence of increased levels of nitrotyrosine, although ONOO is not the only species that can nitrate tyrosine, and myeloperoxidase-dependent reactions may sometimes be more important in vivo [129–132].”
BackgroundPodrez, E. A., Poliakov, E., Shen, Z., Zhang, R., Deng, Y., Sun, M., Finton, P. J., Shan, L., Gugiu, B., Fox, P. L., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203318200 · Cited by 449
Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins
Lau, D., Mollnau, H., Eiserich, J. P., Freeman, B. A., Daiber, A., Gehling, U. M., Brümmer, J., Rudolph, V., Münzel, T., Heitzer, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405193102 · Cited by 434
Self-citationZhang, R., Brennan, M.-L., Shen, Z., MacPherson, J. C., Schmitt, D., Molenda, C. E., & Hazen, S. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209124200 · Cited by 432
Self-citationMyeloperoxidase-derived oxidation: Mechanisms of biological damage and its prevention
Davies, M. J. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-006fr · Cited by 412
Sugiyama, S., Kugiyama, K., Aikawa, M., Nakamura, S., Ogawa, H., & Libby, P. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000131784.50633.4f · Cited by 414
Biological significance of nitric oxide-mediated protein modifications
Gow, A. J., Farkouh, C. R., Munson, D. A., Posencheg, M. A., & Ischiropoulos, H. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00295.2003 · Cited by 385
Thomas, S. R., Witting, P. K., & Drummond, G. R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2027 · Cited by 383
“Such binding is required for the subsequent internalization and transcytosis of MPO through the endothelial cell, resulting in the deposition of the enzyme into the subendothelial space (26).”
InfluentialNO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response?
Schopfer, F. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.10.006 · Cited by 368
Oxidative Stress in Severe Pulmonary Hypertension
Bowers, R., Cool, C., Murphy, R. C., Tuder, R. M., Hopken, M. W., Flores, S. C., & Voelkel, N. F. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-147oc · Cited by 366
Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans
Vita, J. A., Brennan, M.-L., Gokce, N., Mann, S. A., Goormastic, M., Shishehbor, M. H., Penn, M. S., Keaney, J. F., & Hazen, S. L. (2004) · Circulation · doi:10.1161/01.cir.0000140262.20831.8f · Cited by 365
Self-citationAn abundant dysfunctional apolipoprotein A1 in human atheroma
Huang, Y., DiDonato, J. A., Levison, B. S., Schmitt, D., Li, L., Wu, Y., Buffa, J., Kim, T., Gerstenecker, G. S., Gu, X., et al. (2014) · Nature Medicine · doi:10.1038/nm.3459 · Cited by 364
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation
Rudolph, V., Andrié, R. P., Rudolph, T. K., Friedrichs, K., Klinke, A., Hirsch-Hoffmann, B., Schwoerer, A. P., Lau, D., Fu, X., Klingel, K., et al. (2010) · Nature Medicine · doi:10.1038/nm.2124 · Cited by 349
Self-citationMyeloperoxidase in kidney disease
Malle, E., Buch, T., & Grone, H.-J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00336.x · Cited by 349
Parker, H., Albrett, A. M., Kettle, A. J., & Winterbourn, C. C. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0711387 · Cited by 340
The Role of Myeloperoxidase in Biomolecule Modification, Chronic Inflammation, and Disease
Davies, M. J., & Hawkins, C. L. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8030 · Cited by 332
“MPO can also induce endothelial dysfunction via HOCl-independent pathways, including by directly reducing NO (cid:2) bioavailability (56, 206), or mediating damage to extracellular matrix proteins following its transmigration through the endothelium (13).”
Bacteria-Induced Intestinal Cancer in Mice with DisruptedGpx1andGpx2Genes
Chu, F.-F., Esworthy, R. S., Chu, P. G., Longmate, J. A., Huycke, M. M., Wilczynski, S., & Doroshow, J. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2272 · Cited by 306
Myeloperoxidase and its contributory role in inflammatory vascular disease
Lau, D., & Baldus, S. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.023 · Cited by 277
Self-citationSystemic Microvascular Dysfunction and Inflammation after Pulmonary Particulate Matter Exposure
Nurkiewicz, T. R., Porter, D. W., Barger, M., Millecchia, L., Rao, K. M. K., Marvar, P. J., Hubbs, A. F., Castranova, V., & Boegehold, M. A. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8413 · Cited by 267
Pennathur, S., Bergt, C., Shao, B., Byun, J., Kassim, S. Y., Singh, P., Green, P. S., McDonald, T. O., Brunzell, J., Chait, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406762200 · Cited by 264
Askari, A. T., Brennan, M.-L., Zhou, X., Drinko, J., Morehead, A., Thomas, J. D., Topol, E. J., Hazen, S. L., & Penn, M. S. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021426 · Cited by 249
Self-citationMyeloperoxidase: A Useful Biomarker for Cardiovascular Disease Risk Stratification?
Schindhelm, R. K., van der Zwan, L. P., Teerlink, T., & Scheffer, P. G. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.126029 · Cited by 234
“MPO released by these adherent leukocytes is initially bound to the vascular endothelium and subsequently transcytosed to the subendothelial matrix (25).”
BackgroundBaker, P. R. S., Schopfer, F. J., Sweeney, S., & Freeman, B. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402587101 · Cited by 201
Self-citationMyeloperoxidase: A Leukocyte-Derived Protagonist of Inflammation and Cardiovascular Disease
Nussbaum, C., Klinke, A., Adam, M., Baldus, S., & Sperandio, M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4783 · Cited by 195
“Further investigations revealed that the favored binding partner of MPO is the perlecan-FIG constituent heparansulfate glycosaminoglycan (GAG), which is the main component of the endothelial glycocalyx (17, 110).”
InfluentialSelf-citationNitric Oxide-dependent Generation of Reactive Species in Sickle Cell Disease
Aslan, M., Ryan, T. M., Townes, T. M., Coward, L., Kirk, M. C., Barnes, S., Alexander, C. B., Rosenfeld, S. S., & Freeman, B. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208916200 · Cited by 167
Self-citationExpression of Human Myeloperoxidase by Macrophages Promotes Atherosclerosis in Mice
McMillen, T. S., Heinecke, J. W., & LeBoeuf, R. C. (2005) · Circulation · doi:10.1161/circulationaha.104.516278 · Cited by 167
Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells
Tiruppathi, C., Naqvi, T., Wu, Y., Vogel, S. M., Minshall, R. D., & Malik, A. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401712101 · Cited by 159
Conjugated linoleic acid is a preferential substrate for fatty acid nitration
Bonacci, G., Baker, P. R. S., Salvatore, S. R., Shores, D., Khoo, N. K. H., Koenitzer, J. R., Vitturi, D. A., Woodcock, S. R., Golin-Bisello, F., Cole, M. P., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401356 · Cited by 147
“Nitration of CLA by Myeloperoxidase and Peroxynitrite— During inflammation, neutrophil MPO catalyzes biomolecule nitration (33).”
BackgroundSelf-citationReactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications
Casas, A. I., Dao, V. T.-V., Daiber, A., Maghzal, G. J., Di Lisa, F., Kaludercic, N., Leach, S., Cuadrado, A., Jaquet, V., Seredenina, T., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6433 · Cited by 136
“MPO binds to endothelial cells via heparin sulfate glycosaminoglycan, and heparin prevents and reverses such binding (9).”
BackgroundDavies, M. J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107685 · Cited by 119
Lim, D. G., Sweeney, S., Bloodsworth, A., White, C. R., Chumley, P. H., Krishna, N. R., Schopfer, F., O'Donnell, V. B., Eiserich, J. P., & Freeman, B. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232409599 · Cited by 110
Self-citationMo, L., Wang, Y., Geary, L., Corey, C., Alef, M. J., Beer-Stolz, D., Zuckerbraun, B. S., & Shiva, S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.080 · Cited by 62
“(E-F) Rates of (E) ATP and (F) H2O2 generation in cells treated with NO2− (50 μM) for 6 d at 1% O2.”
BackgroundInfluentialStored Iron and Vascular Reactivity
Sullivan, J. L. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000174124.20147.22 · Cited by 41
Halogenation Activity of Mammalian Heme Peroxidases
Arnhold, J., & Malle, E. (2022) · Antioxidants · doi:10.3390/antiox11050890 · Cited by 40
Role of hypohalous acids in basement membrane homeostasis
Colon, S., Page-McCaw, P., & Bhave, G. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7245 · Cited by 38
“Although PXDN is directly associated with BM, other animal heme peroxidases, namely myeloperoxidase (MPO) and eosinophil peroxidase (EPO), are secreted by activated leukocytes into the extracellular space and often directly bind to BM (6, 57, 105).”
Background
Metadata
- Authors
- Baldus, S., Eiserich, J. P., Mani, A., Castro, L., Figueroa, M., Chumley, P., Ma, W., Tousson, A., White, C. R., Bullard, D. C., Brennan, M.-L., Lusis, A. J., Moore, K. P., & Freeman, B. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-12-15
- Volume
- 108
- Issue
- 12
- Pages
- 1759-1770
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2158069865
- Cited by
- 333
- References
- 73
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.